Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study

Cihan Yurdaydin; Ramazan Idilman; Cagdas Kalkan; Fatih Karakaya; Aysun Caliskan Kartal; Onur Keskin; Ersin Karatayli; Senem C. Karatayli; A. Mithat Bozdayi; Christopher Koh; Theo Heller; Jeffrey Glenn

Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study

Cihan Yurdaydin
, Ramazan Idilman
, Cagdas Kalkan
, Fatih Karakaya
, Aysun Caliskan Kartal
, Onur Keskin
, Ersin Karatayli
, Senem C. Karatayli
, A. Mithat Bozdayi
, Christopher Koh
, Theo Heller
, Jeffrey Glenn

Division of Internal Medicine (Medicine)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	910A-911A
Number of pages	2
Journal	Hepatology
Volume	64
Publication status	Published - Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{880869b8398e4b7d978f7c30ee6ec359,

title = "Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study",

author = "Cihan Yurdaydin and Ramazan Idilman and Cagdas Kalkan and Fatih Karakaya and Kartal, \{Aysun Caliskan\} and Onur Keskin and Ersin Karatayli and Karatayli, \{Senem C.\} and Bozdayi, \{A. Mithat\} and Christopher Koh and Theo Heller and Jeffrey Glenn",

year = "2016",

month = oct,

language = "English",

volume = "64",

pages = "910A--911A",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study

AU - Yurdaydin, Cihan

AU - Idilman, Ramazan

AU - Kalkan, Cagdas

AU - Karakaya, Fatih

AU - Kartal, Aysun Caliskan

AU - Keskin, Onur

AU - Karatayli, Ersin

AU - Karatayli, Senem C.

AU - Bozdayi, A. Mithat

AU - Koh, Christopher

AU - Heller, Theo

AU - Glenn, Jeffrey

PY - 2016/10

Y1 - 2016/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000385493804206&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0270-9139

VL - 64

SP - 910A-911A

JO - Hepatology

JF - Hepatology

ER -

Exploring Optimal Dosing Of Lonafarnib With Ritonavir For The Treatment Of Chronic Delta Hepatitis-Interim Results From The Lowr Hdv-2 Study

UN SDGs

Other files and links

Cite this